Feature Channels:

Pharmaceuticals

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

First Structural Views of the NMDA Receptor in Action Will Aid Drug Development

114504_web.jpg

Structural biologists at Cold Spring Harbor Laboratory (CSHL) and Janelia Research Campus/HHMI, have obtained snapshots of the activation of an important type of brain-cell receptor. Dysfunction of the receptor has been implicated in a range of neurological illnesses, including Alzheimer's disease, Parkinson's disease, depression, seizure, schizophrenia, autism, and injuries related to stroke.

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 4-May-2016 5:00 PM EDT

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 5-May-2016 12:40 AM EDT

Medicine

Channels:

What’s Behind the Heartbreaking Risk of Anti-Inflammatory Drugs

thinkstockphotos-140279061-397x263.jpg

Researchers have known for more than a decade that the risk of heart disease and stroke increases when people take pain relievers like ibuprofen and other non-steroidal anti-inflammatory drugs, or NSAIDs. Now, scientists from the University of California, Davis, have uncovered some of the reasons why these drugs can harm heart tissue.

Medicine

Channels:

Keywords:

Screening Method Uncovers Drugs That May Combat Deadly Antibiotic-Resistant Bacteria

CRErls.jpg

In recent years, hospitals have reported dramatic increases in the number of cases of the highly contagious, difficult-to-treat, and often deadly antibiotic-resistant bacteria carbapenem-resistant Enterobacteriaceae (CRE). Now, investigators at Beth Israel Deaconess Medical Center (BIDMC) have developed a promising method of identifying new antimicrobials that target these organisms. The research is published in April issue of the journal ASSAY and Drug Development Technologies.

Medicine

Channels:

Study Shows How Different People Respond to Aspirin — an Important Cardioprotective Drug

Researchers have learned new information about how different people respond to aspirin, a globally prescribed drug in cardioprotection. The team identified more than 5,600 lipids in blood platelets and gained new insights into how these cells respond to aspirin.

Medicine

Channels:

Keywords:

Costs for Orally-Administered Cancer Drugs Skyrocket

Dusetzinapreferred.jpg

An analysis by a University of North Carolina at Chapel Hill researcher reports in JAMA Oncology that a month of treatment with orally-administered cancer drugs introduced in 2014 were, on average, six times more expensive at launch than cancer drugs introduced in 2000 after adjusting for medical inflation. Drugs approved in 2000 cost an average of $1,869 per month compared to $11,325 for those approved in 2014.

Business

Channels:

Keywords:

The Wistar Institute and Cormorant Pharmaceuticals Form Partnership

DSCN5241.JPG

Global collaboration applies Wistar expertise to promising Cormorant therapeutic drug development

Medicine

Science

Channels:

Keywords:

Experimental Drug Cancels Effect From Key Intellectual Disability Gene in Mice

FragileX.jpg

A University of Wisconsin-Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome. The condition, called fragile X, has devastating effects on intellectual abilities.

Medicine

Channels:

Pinellas County a Model for Mosquito-Borne Disease Surveillance, Scientists Unravel the Genetic Evolution of Zika Virus, Worm Infection Counters Inflammatory Bowel Disease and more in the Infectious Diseases News Source

Pinellas County a Model for Mosquito-Borne Disease Surveillance, Scientists Unravel the Genetic Evolution of Zika Virus, Worm Infection Counters Inflammatory Bowel Disease and more in the Infectious Diseases News Source

Medicine

Channels:

Keywords:

Vaccinations Are More Effective When Administered in the Morning

The findings, published in the journal Vaccine, suggest administering vaccinations in the morning, rather than the afternoon, could induce greater, and thus more protective, antibody responses.

Medicine

Channels:

Keywords:

Malaria Expert Available: Volunteers Roll Up Sleeves and Get Infected to Test Experimental Drug in Seattle

JimKublin_1.jpg

Medicine

Life

Law and Public Policy

Channels:

Fighting Against Counterfeit Medicine

113926_web.jpg

Around the world, especially in developing nations, counterfeit medicines are a real problem. Until now, in many countries there hasn't been a standard protocol to conduct investigations and pursue prosecution.

Medicine

Science

Channels:

New Understanding of Enzymes Could Help to Develop New Drugs to Treat Diseases

113997_web.jpg

University of Leicester researchers shed light on the role of inositol phosphate molecules in gene regulatory complexes.

Science

Channels:

Keywords:

New Molecule-Building Method From TSRI Opens Up Vast Realm of Chemistry for Pharma and Other Industries

20160421baranetal.jpg

Scientists at The Scripps Research Institute have devised a new molecule-building method likely to have a major impact on the pharmaceutical industry and other chemistry-based enterprises. The method allows construction of novel, complex and potentially valuable molecules.

Medicine

Channels:

Keywords:

New Treatments for Epilepsy Explored in Upcoming Session

Drugs, alternative therapies, medical devices and medical marijuana are discussed in this session open to epilepsy patients and families, pet owners, veterinarians and physicians.

Medicine

Channels:

Keywords:

New Method Enlists Electricity for Easier, Cheaper, Greener Chemistry

baran_horn.jpg

Scientists at The Scripps Research Institute have found a new and better way to achieve a chemical reaction that is used widely in the pharmaceutical as well as flavor and fragrance industries.

Medicine

Science

Life

Business

Arts and Humanities

Channels:

Vitamins May Protect Against Nerve Damage in Breast Cancer Treatment, and more Cancer News in the Newswise Channels

click to visit the Cancer Channel

Medicine

Science

Life

Business

Arts and Humanities

Channels:

The Role of Family and the Media in Childhood Obesity, and more Children's Health News in the Newswise Channels

Click to visit the Children's Health Channel

Medicine

Channels:

Keywords:

Longest Follow-Up of Survival After Treatment with Nivolumab Reported at AACR Annual Meeting 2016

A team of researchers led by Ludwig Cancer Research scientist Stephen Hodi reported today the results of the longest follow-up survival study conducted to date on patients with advanced melanoma who were treated with the PD-1 inhibitor nivolumab. Hodi and his colleagues announced at a press event during the American Association for Cancer Research Annual Meeting in New Orleans that 34 percent of the patients treated with this immunotherapy alone in a previous Phase 1 trial were still alive five years later.